Perma-Fix Environmental Services, Inc.  

(Public, NASDAQ:PESI)   Watch this stock  
Find more results for PESI
+0.03 (0.65%)
Jul 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 4.63 - 4.63
52 week 3.42 - 5.64
Open 4.63
Vol / Avg. 182.00/20,639.00
Mkt cap 54.54M
P/E     -
Div/yield     -
EPS -0.09
Shares 11.57M
Beta 1.28
Inst. own 39%
Aug 4, 2016
Q2 2016 Perma-Fix Environmental Services Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 26, 2016
Perma-Fix Environmental Services Inc at B. Riley Investor Conference
May 17, 2016
Q1 2016 Perma-Fix Environmental Services Inc Earnings Call
May 17, 2016
Q1 2016 Perma-Fix Environmental Services Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -38.31% -0.10%
Operating margin -35.87% 1.82%
EBITD margin - 7.65%
Return on average assets -19.18% -0.07%
Return on average equity -34.50% 1.82%
Employees 258 -
CDP Score - -


8302 Dunwoody Pl Ste 250
ATLANTA, GA 30350-3390
United States - Map
+1-770-5879898 (Phone)
+1-770-5879937 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Perma-Fix Environmental Services, Inc. is an environmental and environmental technology know-how company. It operates in three segments: The Treatment Segment (Treatment), the Services Segment (Services) and the Medical Segment (Medical). Treatment includes nuclear, low-level radioactive, mixed (waste containing both hazardous and low-level radioactive waste), hazardous and non-hazardous waste treatment, processing and disposal services primarily through approximately four licensed and permitted treatment and storage facilities held by its subsidiaries. Services include on-site waste management services to commercial and government customers, technical services and nuclear services. The Medical segment includes research and development (R&D) of a new medical isotope production technology by its Polish subsidiary, Perma-Fix Medical S.A. (PF Medical). Its Treatment and Services provide services to research institutions, commercial companies, public utilities and governmental agencies.

Officers and directors

Larry Morse Shelton Chairman of the Board
Age: 61
Bio & Compensation  - Reuters
Louis Francis Centofanti President, Chief Executive Officer
Age: 72
Bio & Compensation  - Reuters
Ben Naccarato Chief Financial Officer, Vice President, Secretary
Age: 52
Bio & Compensation  - Reuters
John Lash Chief Operating Officer
Age: 52
Bio & Compensation  - Reuters
Mark Duff Executive Vice President
Age: 53
Bio & Compensation  - Reuters
Mark A. Zwecker Lead Independent Director
Age: 64
Bio & Compensation  - Reuters
John Michael Climaco J.D. Director
Bio & Compensation  - Reuters
Gary Kugler Independent Director
Age: 74
Bio & Compensation  - Reuters
Jack Lahav Independent Director
Age: 66
Bio & Compensation  - Reuters
Joe R. Reeder Independent Director
Age: 67
Bio & Compensation  - Reuters